The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off
The largest Phase 3 clinical trial investigating the efficacy and tolerability of psilocybin for treatment-resistant depression (TRD) has finally begun.
Day: June 1, 2023
Exclusive: Beckley Waves Establishes Ethics Council to Guide Psychedelic Industry Standards
Beckley Waves has formed a new Ethics Council.
End of content
End of content